Predictors of mortality in chronic pulmonary aspergillosis
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Chronic pulmonary aspergillosis (CPA) is a chronic progressive infection that destroys lung tissue in non-immunocompromised patients. Contemporary series suggest 50–85% 5-year mortality, with few prognostic factors identified. A cohort of 387 CPA patients referred to the UK's National Aspergillosis Centre from 1992 to June 2012 was studied until June 2015. The impact of objective and subjective variables including age, sex, previous pulmonary conditions, dyspnoea score, quality of life, serum albumin and C-reactive protein and radiological appearances were assessed using Kaplan–Meier curves, log rank tests and Cox proportional hazards modelling. In samples of patients, retrospective review of time from likely onset of CPA to referral and cause of death were also investigated. Survival was 86%, 62% and 47% at 1, 5 and 10 years, respectively. Increased mortality was associated with nontuberculous mycobacterial infection (hazard ratio 2.07, 95% CI 1.22–3.52; p<0.001) and chronic obstructive pulmonary disease (1.57, 1.05–2.36; p=0.029) as well as higher age (1.053, 1.03–1.07 per year; p<0.001), lower albumin (0.92, 0.87–0.96 per g·L −1 ), lower activity (1.021, 1.01–1.03 per point increase in St George's Respiratory Questionnaire activity domain; p<0.001) and having one, and especially, bilateral aspergillomas (p<0.001). Several factors impact on mortality of CPA, and can be evaluated as tools to assess CPA prognosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a cohort of 387 CPA patients referred to the UK’s National Aspergillosis Centre from 1992 to June 2012, survival was 86%, 62% and 47% at 1, 5 and 10 years, respectively [135].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [135]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 53 · Cited by 194
Research works printed but not linked: 3
- Ishikawa, 2011, Kekkaku, 86, 781
- Fujiuchi, 2008, Kekkaku, 83, 573
- 10.1164/rccm.200506-969OC · doi:10.1164/rccm.200506-969oc · Paper page
Metadata
- Authors
- Lowes, D., Al-Shair, K., Newton, P. J., Morris, J., Harris, C., Rautemaa-Richardson, R., & Denning, D. W.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2016-12-19
- Volume
- 49
- Issue
- 2
- Pages
- 1601062
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2565643097
- Cited by
- 194
- References
- 53
- Citations by year
- 2026: 26 · 2025: 13 · 2024: 24 · 2023: 24 · 2022: 24 · 2021: 20 · 2020: 20 · 2019: 13 · 2018: 17 · 2017: 10
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Microbiology (medical) › Actinomycetales infections and treatment
- Keywords
- chronic pulmonary aspergillosis, mortality, prognostic factors, nontuberculous mycobacterial infection, chronic obstructive pulmonary disease, serum albumin, St George's Respiratory Questionnaire, aspergilloma, quality of life, dyspnea, C-reactive protein, survival
- MeSH terms
- Serum Albumin, Human, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, C-Reactive Protein, Chronic Disease, Female, United Kingdom, Humans, Lung, Male, Middle Aged, Mycobacterium Infections, Nontuberculous, Prognosis, Quality of Life, Retrospective Studies, Risk Factors, Triazoles, Survival Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Aspergillosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of mortality in chronic pulmonary aspergillosis. https://app.cochat.ai/papers/10.1183/13993003.01062-2016
- The paper
- Lowes, D., Al-Shair, K., Newton, P. J., Morris, J., Harris, C., Rautemaa-Richardson, R., & Denning, D. W. (2017). Predictors of mortality in chronic pulmonary aspergillosis. European Respiratory Journal. https://doi.org/10.1183/13993003.01062-2016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.